ABSTRACT Background/Objectives Bruton tyrosine kinase inhibitors (BTKis) have revolutionized treatment for chronic lymphocytic leukemia (CLL), but cardiovascular (CV) toxicities pose significant challenges. Second‐generation BTKis offer improved target specificity, yet CV risks persist.
Stefano Oliva, Stefano Molica
wiley +1 more source
A Case of Premature Ventricular Contraction-Induced Cardiomyopathy. [PDF]
Mazar M, Hingorany S.
europepmc +1 more source
Left ventricular remodeling in premature ventricular contraction-induced cardiomyopathy: Effect of coupling intervals and atrioventricular dissociation. [PDF]
Shoureshi P +9 more
europepmc +1 more source
Premature Ventricular Contraction Location and Incident Heart Failure. [PDF]
Dewland TA +13 more
europepmc +1 more source
Idiopathic premature ventricular contraction-triggered ventricular fibrillation: Subcutaneous implantable cardioverter-defibrillator (S-ICD) template matched ablation in the absence of inducible clinical premature ventricular contraction. [PDF]
Mekala SR, Davis M, Srivathsan K.
europepmc +1 more source
Approaches to the treatment of the premature ventricular contractions in a young patient with anomalous origin of the right coronary artery from the left sinus of Valsalva [PDF]
E.S. Kotanova +4 more
openalex +1 more source
Not Premature to Quantitatively Define the Near-Field Bipolar Electrogram for Premature Ventricular Contraction Ablation. [PDF]
Ji S, Gupta N, Qu Z.
europepmc +1 more source
Speckle tracking technology and investigation of risk factors for premature ventricular contraction-induced cardiomyopathy. [PDF]
Ma Q +5 more
europepmc +1 more source
1:1 Tachycardia initiated by a premature ventricular contraction: The curious appeal of the peel. [PDF]
Cerna L +4 more
europepmc +1 more source

